Potential risks associated with increased plasma plant-sterol levels

Diabetes and Metabolism

Volumn 41, Issue 1, 2015, Pages 76-81

  Verges B ^a   Fumeron, F ^b  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Cardiovascular; Plant sterol; Risks; Sitosterolaemia

Indexed keywords

CAMPESTEROL; PHYTOSTEROL; SITOSTEROL;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; GENETIC ASSOCIATION; HUMAN; IN VITRO STUDY; LIPID BLOOD LEVEL; NONHUMAN; PROSPECTIVE STUDY; RISK ASSESSMENT; ANIMAL; ATHEROSCLEROTIC PLAQUE; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ENTEROPATHY; EPIDEMIOLOGY; FEMALE; HYPERCHOLESTEROLEMIA; MALE; MOUSE; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INTESTINAL DISEASES; LIPID METABOLISM, INBORN ERRORS; MALE; MICE; PHYTOSTEROLS; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS;

EID: 84921729020     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2014.11.003     Document Type: Article

References (49)

1. Salen G., Shefer S., Nguyen L., Ness G.C., Tint G.S., Shore V. Sitosterolemia. J Lipid Res 1992, 33:945-955.
2. Fransen H.P., de Jong N., Wolfs M., Verhagen H., Verschuren W.M.M., Lütjohann D., et al. Customary use of plant sterol and plant stanol enriched margarine is associated with changes in serum plant sterol and stanol concentrations in humans. J Nutr 2007, 137:1301-1306.
3. Naumann E., Plat J., Mensink R.P. Changes in serum concentrations of non-cholesterol sterols and lipoproteins in healthy subjects do not depend on the ratio of plant sterols to stanols in the diet. J Nutr 2003, 133:2741-2747.
4. Lottenberg A.M., Bombo R.P.A., Ilha A., Nunes V.S., Nakandakare E.R., Quintão E.C.R. Do clinical and experimental investigations support an antiatherogenic role for dietary phytosterols/stanols?. IUBMB Life 2012, 64:296-306.
5. Silbernagel G., Genser B., Nestel P., März W. Plant sterols and atherosclerosis. Curr Opin Lipidol 2013, 24:12-17.
6. Vergès B., Athias A., Petit J.-M., Brindisi M.-C. Extravascular lipid deposit (xanthelasma) induced by a plant sterol-enriched margarine. BMJ Case Rep 2009, [Internet]. Available from:, [cited 2011 Nov. 2]. http://www.ncbi.nlm.nih.gov/pubmed/21822448.
7. Glueck C.J., Speirs J., Tracy T., Streicher P., Illig E., Vandegrift J. Relationships of serum plant sterols (phytosterols) and cholesterol in 595hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism 1991, 40:842-848.
8. Rajaratnam R.A., Gylling H., Miettinen T.A. Independent association of serum squalene and non-cholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol 2000, 35:1185-1191.
9. Gylling H., Hallikainen M., Rajaratnam R.A., Simonen P., Pihlajamäki J., Laakso M., et al. The metabolism of plant sterols is disturbed in postmenopausal women with coronary artery disease. Metabolism 2009, 58:401-407.
10. Sudhop T., Gottwald B.M., von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism 2002, 51:1519-1521.
11. Assmann G., Cullen P., Erbey J., Ramey D.R., Kannenberg F., Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study. Nutr Metab Cardiovasc Dis 2006, 16:13-21.
12. Matthan N.R., Pencina M., LaRocque J.M., Jacques P.F., D'Agostino R.B., Schaefer E.J., et al. Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD. J Lipid Res 2009, 50:1927-1935.
13. Weingärtner O., Lütjohann D., Vanmierlo T., Müller S., Günther L., Herrmann W., et al. Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus. Chem Phys Lipids 2011, 164:451-456.
14. Miettinen T.A., Gylling H., Strandberg T., Sarna S., Finnish 4S Investigators Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. BMJ 1998, 316:1127-1130.
15. Thiery J., Ceglarek U., Fiedler G., Leichtle A., Baumann S., Teupser D., et al. Elevated campesterol serum levels-a significant predictor of incident myocardial infarction: results of the population-based MONICA/KORA follow-up study 1994-2005. Circ Abstr 2006, 114:884. [4099].
16. Silbernagel G., Fauler G., Hoffmann M.M., Lütjohann D., Winkelmann B.R., Boehm B.O., et al. The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality. J Lipid Res 2010, 51:2384-2393.
17. Teupser D., Baber R., Ceglarek U., Scholz M., Illig T., Gieger C., et al. Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet 2010, 3:331-339.
18. Koeijvoets K.C.M.C., van der Net J.B., Dallinga-Thie G.M., Steyerberg E.W., Mensink R.P., Kastelein J.J.P., et al. ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia. Atherosclerosis 2009, 204:453-458.
19. Jakulj L., Vissers M.N., Tanck M.W.T., Hutten B.A., Stellaard F., Kastelein J.J.P., et al. ABCG5/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-analysis. J Lipid Res 2010, 51:3016-3023.
20. IBC 50K CAD Consortium Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet 2011, 7:e1002260.
21. Reilly M.P., Li M., He J., Ferguson J.F., Stylianou I.M., Mehta N.N., et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011, 377:383-392.
22. Schunkert H., König I.R., Kathiresan S., Reilly M.P., Assimes T.L., Holm H., et al. Large-scale association analysis identifies 13new susceptibility loci for coronary artery disease. Nat Genet 2011, 43:333-338.
23. Silbernagel G., Fauler G., Renner W., Landl E.M., Hoffmann M.M., Winkelmann B.R., et al. The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease. J Lipid Res 2009, 50:334-341.
24. Weingärtner O., Lütjohann D., Ji S., Weisshoff N., List F., Sudhop T., et al. Vascular effects of diet supplementation with plant sterols. J Am Coll Cardiol 2008, 51:1553-1561.
25. Helske S., Miettinen T., Gylling H., Mäyränpää M., Lommi J., Turto H., et al. Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves. J Lipid Res 2008, 49:1511-1518.
26. Miettinen T.A., Railo M., Lepäntalo M., Gylling H. Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. J Am Coll Cardiol 2005, 45:1794-1801.
27. Wilund K.R., Yu L., Xu F., Vega G.L., Grundy S.M., Cohen J.C., et al. No association between plasma levels of plant sterols and atherosclerosis in mice and men. Arterioscler Thromb Vasc Biol 2004, 24:2326-2332.
28. Shay C.M., Evans R.W., Orchard T.J. Do plant sterol concentrations correlate with coronary artery disease in type 1 diabetes? A report from the Pittsburgh Epidemiology of Diabetes Complications Study. J Diabetes 2009, 1:112-117.
29. Windler E., Zyriax B.-C., Kuipers F., Linseisen J., Boeing H. Association of plasma phytosterol concentrations with incident coronary heart disease data from the CORA study, a case-control study of coronary artery disease in women. Atherosclerosis 2009, 203:284-290.
30. Pinedo S., Vissers M.N., von Bergmann K., Elharchaoui K., Lütjohann D., Luben R., et al. Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-Norfolk Population Study. J Lipid Res 2007, 48:139-144.
31. Escurriol V., Cofán M., Moreno-Iribas C., Larrañaga N., Martínez C., Navarro C., et al. Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort. J Lipid Res 2010, 51:618-624.
32. Fassbender K., Lütjohann D., Dik M.G., Bremmer M., König J., Walter S., et al. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk--the LASA study. Atherosclerosis 2008, 196:283-288.
33. Strandberg T.E., Gylling H., Tilvis R.S., Miettinen T.A. Serum plant and other non-cholesterol sterols, cholesterol metabolism and 22-year mortality among middle-aged men. Atherosclerosis 2010, 210:282-287.
34. Tilvis R.S., Valvanne J.N., Strandberg T.E., Miettinen T.A. Prognostic significance of serum cholesterol, lathosterol, and sitosterol in old age; a 17-year population study. Ann Med 2011, 43:292-301.
35. Genser B., Silbernagel G., De Backer G., Bruckert E., Carmena R., Chapman M.J., et al. Plant sterols and cardiovascular disease: a systematic review meta-analysis. Eur Heart J 2012, 33:444-451.
36. Sabeva N.S., McPhaul C.M., Li X., Cory T.J., Feola D.J., Graf G.A. Phytosterols differentially influence ABC transporter expression, cholesterol efflux and inflammatory cytokine secretion in macrophage foam cells. J Nutr Biochem 2011, 22:777-783.
37. Weingartner O., Ulrich C., Lutjohann D., Ismail K., Schirmer S.H., Vanmierlo T., et al. Differential effects on inhibition of cholesterol absorption by plant stanol and plant sterol esters in apoE-/- mice. Cardiovasc Res 2011, 90:484-492.
38. Ratnayake W.M., L'Abbé M.R., Mueller R., Hayward S., Plouffe L., Hollywood R., et al. Vegetable oils high in phytosterols make erythrocytes less deformable and shorten the life span of stroke-prone spontaneously hypertensive rats. J Nutr 2000, 130:1166-1178.
39. Ratnayake W.M., Plouffe L., Hollywood R., L'Abbé M.R., Hidiroglou N., Sarwar G., et al. Influence of sources of dietary oils on the life span of stroke-prone spontaneously hypertensive rats. Lipids 2000, 35:409-420.
40. Ratnayake W.M.N., Plouffe L., L'Abbé M.R., Trick K., Mueller R., Hayward S. Comparative health effects of margarines fortified with plant sterols and stanols on a rat model for hemorrhagic stroke. Lipids 2003, 38:1237-1247.
41. Moghadasian M.H., McManus B.M., Pritchard P.H., Frohlich J.J. Tall oil-derived phytosterols reduce atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 1997, 17:119-126.
42. Raitakari O.T., Salo P., Gylling H., Miettinen T.A. Plant stanol ester consumption and arterial elasticity and endothelial function. Br J Nutr 2008, 100:603-608.
43. Hallikainen M., Lyyra-Laitinen T., Laitinen T., Agren J.J., Pihlajamäki J., Rauramaa R., et al. Endothelial function in hypercholesterolemic subjects: effects of plant stanol and sterol esters. Atherosclerosis 2006, 188:425-432.
44. Hallikainen M., Lyyra-Laitinen T., Laitinen T., Moilanen L., Miettinen T.A., Gylling H. Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes. Atherosclerosis 2008, 199:432-439.
45. De Jongh S., Vissers M.N., Rol P., Bakker H.D., Kastelein J.J.P., Stroes E.S.G. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J Inherit Metab Dis 2003, 26:343-351.
46. Jakulj L., Vissers M.N., Rodenburg J., Wiegman A., Trip M.D., Kastelein J.J.P. Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels. J Pediatr 2006, 148:495-500.
47. Plat J., Brzezinka H., Lütjohann D., Mensink R.P., von Bergmann K. Oxidized plant sterols in human serum and lipid infusions as measured by combined gas-liquid chromatography-mass spectrometry. J Lipid Res 2001, 42:2030-2038.
48. Adcox C., Boyd L., Oehrl L., Allen J., Fenner G. Comparative effects of phytosterol oxides and cholesterol oxides in cultured macrophage-derived cell lines. J Agric Food Chem 2001, 49:2090-2095.
49. De Jong A., Plat J., Bast A., Godschalk R.W.L., Basu S., Mensink R.P. Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment. Eur J Clin Nutr 2008, 62:263-273.